2C-B-morpholine

Pharmaceutical compound From Wikipedia, the free encyclopedia

2C-B-morpholine, also known as 2C-B-norphenmetrazine or as 2-(4-bromo-2,5-dimethoxyphenyl)morpholine, is a serotonin receptor modulator of the phenylmorpholine (phenmetrazine) and cyclized phenethylamine groups.[1] It is a ligand of the serotonin 5-HT2A receptor, with an affinity of 20.6 nM and an EmaxTooltip maximal efficacy of 4%.[1] The drug showed 103-fold lower affinity for this receptor than R(–)-DOB and had minimal agonist activity (with R(–)-DOB having an Emax of 51% in the assay), so for practical purposes would act as an antagonist at the 5-HT2A receptor under most circumstances, despite being technically classified as a partial agonist.[1] 2C-B-morpholine was first described in the scientific literature by Richard Glennon and colleagues by 2004.[1]

Other names2C-B-Norphenmetrazine; 2-(4-Bromo-2,5-dimethoxyphenyl)morpholine; 2C-B-MOR; 2C-B-Mor
ATC code
  • None
Legal status
  • In general Unscheduled.
Quick facts Clinical data, Other names ...
2C-B-morpholine
Clinical data
Other names2C-B-Norphenmetrazine; 2-(4-Bromo-2,5-dimethoxyphenyl)morpholine; 2C-B-MOR; 2C-B-Mor
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor ligand
ATC code
  • None
Legal status
Legal status
  • In general Unscheduled.
Identifiers
  • 2-(4-bromo-2,5-dimethoxyphenyl)morpholine
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC12H16BrNO3
Molar mass302.168 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1C2CNCCO2)OC)Br
  • InChI=1S/C12H16BrNO3/c1-15-10-6-9(13)11(16-2)5-8(10)12-7-14-3-4-17-12/h5-6,12,14H,3-4,7H2,1-2H3
  • Key:OUTZYBJUJMETRJ-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI